Skip to Content

Health

FDA says Johnson & Johnson Covid-19 vaccine meets requirements for emergency use authorization

In an analysis released Wednesday, the US Food and Drug Administration said the Johnson & Johnson Covid-19 vaccine has met the requirements for emergency use authorization. The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all geographic areas was 66.9% at least 14 days after the single dose vaccination and

Continue Reading

Experts worry variant-fueled surge of Covid-19 could be weeks away but cases will likely fall again by summer

Coronavirus infections across the US are still on the way down, and more Americans are getting vaccinated — but variants could cause complications soon. Several experts predicted Tuesday the highly contagious B.1.1.7 variant first detected in the UK is likely to fuel another surge of cases in just a matter of weeks. “It could result

Continue Reading

FDA advisers to consider recommending single-dose Johnson & Johnson Covid-19 vaccine this week

Vaccine advisers to the US Food and Drug Administration will meet Friday to discuss whether to recommend Johnson & Johnson’s Covid-19 vaccine for emergency use authorization. The vaccine is the third under consideration for the US market, and would be the first single-dose Covid-19 shot available here. Like the earlier Covid-19 vaccines, it was developed

Continue Reading